Healthy Beginnings

Resurgence of “Old” Therapy offers New Hope. Ultraviolet Blood Irradiation

The practice of UBI Therapy began in the 1920’s when a UBI device was developed for extracorporeal (outside the body) treatment of the blood. By the 1940’s, UBI came to be used to treat things like bacterial, viral and autoimmune diseases. Researchers came to understand that the central mechanism of the therapy was the secondary emissions of biophotons from blood cells activated by the treatment. But, enthusiasm over the new antibiotics and vaccines in the 1950’s caused the UBI device to be placed on the shelf even though, for certain indications (hepatitis, herpes and viral pneumonia), UBI was demonstrably superior.

The development of multidrug resistance to antibiotics in recent years and the search for less toxic therapies have led to a renewed interest in UBI Therapy. By now, millions of patients have been successfully treated with UBI and scores of clinical trials have been conducted in Russia, Ukraine and the former East Germany. UBI is also currently used by some physicians in China and the United States.

UBI Therapy is effective against many disorders. It was a significant lapse for American medical science to ignore the documentation (including several controlled studies) that developed over 30 years, beginning in 1928, regarding UBI treatment of hundreds of thousands of patients by reputable physicians. It is especially hard to justify this oversight given the intense effort to identify promising approaches to the treatment of HIV and related viral conditions.

The Ultraviolet treatment of the blood in the treatment chamber destroys or alters bacteria and viruses in the extracted blood in such a way, as to create a kind of vaccination effect when they return to the body. This provokes a reaction by the immune system, which in turn destroys most or all of the other bacteria or viruses in the body.
The treatment is demonstrated to stimulate the normal red blood cells to emit a kind of light called “biophotons.” The treatment of a small fraction (5 percent) of the blood then spreads throughout the entire volume of the blood, upon returning to the body. This secondary radiation, (biophotons emitted by the activated cells), destroys viruses, bacteria and (in autoimmune diseases) activated white blood cells. In autoimmune disorders, it appears that the metabolically active T-cells and other immune cells absorb much greater numbers of biophotons than ordinary body and immune cells, and this destroys them, thus slowing or stopping the disease.

By the 1940’s, the results of UBI treatments were not only found to be beneficial in treating all kinds of infections, but also included inactivation of toxins; as well as an increase in the oxygen combining power of the blood and oxygen transportation to organs, activation of steroid hormones, dilation of blood vessels, activation of white blood cells, stimulation of cellular and humoral immunity, fibrinolysis, decreased viscosity of blood, improved microcirculation and decreased platelet aggregation.

It is successfully used to treat viral and bacterial pneumonia, polio, botulism, non-healing wounds, encephalitis, peritonitis, asthma, hepatitis, chronic fatigue, fibromyalgia, rheumatoid arthritis, and many other infectious, inflammatory, and autoimmune disorders.

The FDA approved the principle that ultraviolet treatment of the blood can convey therapeutic benefit. This wonderful new/old non-toxic, therapeutic tool is becoming more and more available to the public. It seems like a treatment whose time has come…again!


  1. Han, V.K., “Treatment of Blood Stream Infections with Hemo-(UV) Irradiation. Case Reports.” American Journal of Surgery 58:3:336-44 (1942)
  2. Olney, R.C. et al. “Treatment of Viral Hepatitis with Knott Technic of (UV) Blood Irradiation”, American Journal of Surgery, 90:3:402-9 (1955)
  3. Iakovlev, V.A. et al. “The Mechanisms of the Theraputic Action and the Basis for Performing Sessions of Ultraviolet Blood Irradiation in Treating Acute Pneumonia [Russian],” Terapevticheskii Arkhiv 66:8:39-42 (1994)

For more info, contact Reno Integrative Medical Center at (775) 829-1009 or visit online at